Volatile Anesthetics and Respiratory Neurotransmission
挥发性麻醉剂和呼吸神经传递
基本信息
- 批准号:7619179
- 负责人:
- 金额:$ 24.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-05-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsAdrenergic ReceptorAgonistAlveolarAnesthesia proceduresAnestheticsBrain StemBreathingCanis familiarisChemicalsClinicalCoupledDataDefense MechanismsFigs - dietaryFrequenciesGTP-Binding ProteinsGlutamate ReceptorGlutamatesGoalsHalothaneHypoglossal nerve structureIn VitroInfluentialsIsofluraneLigandsMeasuresMediatingMembraneMethodsModelingMorbidity - disease rateMotor NeuronsMuscleNerveNervous system structureNeuromodulatorNeuronsNeurotransmitter ReceptorNeurotransmittersParalysedPatientsPatternPerioperativePharmacologyPhysiologicalPhysiologyPostoperative PeriodPotassium ChannelPredispositionPreparationPumpRelative (related person)Research PersonnelRespiratory SystemStructure of phrenic nerveSynapsesSynaptic TransmissionSystemTestingTherapeutic InterventionTimeTonguebaseclinically relevantdepresseddepressionextracellularhigh riskin vivoinsightmotor controlneuronal excitabilityneurophysiologyneuroregulationneurotransmissionneurotransmitter agonistneurotransmitter antagonistneurotransmitter releasepostsynapticpressurepresynapticprogramsreceptorrespiratoryresponsesevofluranetransmission process
项目摘要
DESCRIPTION (provided by applicant): Subanesthetic concentrations of volatile anesthetics potently depress upper airway defense mechanisms. In particular, hypoglossal motor control of the tongue that maintains airway patency during inspiration is severely compromised. The overall goal of this proposal is to characterize the actions of volatile anesthetics on specific synaptic mechanisms and neuronal excitability within spontaneously active mammalian inspiratory hypoglossal motoneurons (IHMNs) in vivo. While in vitro studies have identified potential mechanisms for anesthetic-induced depression, this proposal is unique because we focus on functionally identified IHMNs in an intact neuronal network under in vivo conditions, where neurotransmitters are released at physiologically relevant levels. Our overall hypothesis is 1) that the activity of IHMNs is dependent on synaptic inputs mediated by ligand-gated glutamatergic, GABAergic, and glycinergic and G-protein coupled serotonergic and adrenergic receptors, and 2) the effects of volatile anesthetics on neuronal activity are due to depression of excitatory and enhancement of inhibitory synaptic neurotransmission, rather than non-synaptically mediated intrinsic membrane mechanisms such as changes in K+conductance. Recordings of action potentials from IHMNs in conjunction with localized pressure microejection of neurotransmitter agonists and antagonists will be used to examine the relative importance of anesthetic-induced alterations on excitatory and inhibitory neurotransmission and intrinsic neuronal excitability. Three specific aims have been developed to test our hypothesis in a decerebrate canine model. In specific aim 1, we will identify the key contributing neurotransmitters in IHMNs and determine their physiological receptor activity. In specific aim 2, we will determine the effect of subanesthetic concentrations of volatile anesthetics on overall synaptic transmission of the key neurotransmitter systems in IHMNs. In specific aim 3, we will determine the effects of volatile anesthetics on the postsynaptic receptor responses for the key contributing neurotransmitters in IHMNs. The insights that will be gained from our proposed studies will contribute to our understanding of the effects of volatile anesthetics on upper airway function in the perioperative period and may suggest rational mechanism-based therapeutic interventions to mitigate these effects in the postoperative setting when patients are at high risk of airway- related morbidity.
描述(由申请人提供):亚麻醉浓度的挥发性麻醉药有效抑制上呼吸道防御机制。特别是,在吸气过程中保持气道通畅的舌下神经运动控制严重受损。本提案的总体目标是表征挥发性麻醉剂在体内自发活动的哺乳动物吸气舌下神经运动神经元(IHMN)内对特定突触机制和神经元兴奋性的作用。虽然体外研究已经确定了麻醉诱导抑郁症的潜在机制,但该建议是独特的,因为我们专注于在体内条件下完整神经元网络中功能鉴定的IHMN,其中神经递质以生理相关水平释放。我们的总体假设是1)IHMN的活性依赖于由配体门控的谷氨酸能、GABA能和甘氨酸能以及G蛋白偶联的多巴胺能和肾上腺素能受体介导的突触输入,以及2)挥发性麻醉剂对神经元活性的影响是由于兴奋性突触神经传递的抑制和抑制性突触神经传递的增强,而不是非突触介导的内在膜机制,如K+电导的变化。将使用IHMN的动作电位记录结合神经递质激动剂和拮抗剂的局部压力微喷射来检查麻醉诱导的改变对兴奋性和抑制性神经传递以及内在神经元兴奋性的相对重要性。三个具体的目标已经开发,以测试我们的假设在去大脑犬模型。在具体目标1中,我们将确定IHMN中的关键神经递质并确定其生理受体活性。在具体目标2中,我们将确定亚麻醉浓度的挥发性麻醉剂对IHMN中关键神经递质系统的整体突触传递的影响。在具体目标3中,我们将确定挥发性麻醉剂对IHMN中关键神经递质的突触后受体反应的影响。从我们拟定的研究中获得的见解将有助于我们了解挥发性麻醉药对围手术期上气道功能的影响,并可能建议合理的基于机制的治疗干预措施,以减轻患者在术后气道相关发病率高风险时的这些影响。
项目成果
期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effects of halothane on excitatory neurotransmission to medullary expiratory neurons in a decerebrate dog model.
氟烷对去大脑狗模型中髓质呼气神经元兴奋性神经传递的影响。
- DOI:10.1097/00000542-200012000-00020
- 发表时间:2000
- 期刊:
- 影响因子:8.8
- 作者:Stuth,EA;Krolo,M;Stucke,AG;Tonkovic-Capin,M;Tonkovic-Capin,V;Hopp,FA;Kampine,JP;Zuperku,EJ
- 通讯作者:Zuperku,EJ
Anesthetic effects on synaptic transmission and gain control in respiratory control.
麻醉对呼吸控制中突触传递和增益控制的影响。
- DOI:10.1016/j.resp.2008.05.007
- 发表时间:2008
- 期刊:
- 影响因子:2.3
- 作者:Stuth,EckehardA;Stucke,AstridG;Brandes,IvoF;Zuperku,EdwardJ
- 通讯作者:Zuperku,EdwardJ
Opioid receptors on bulbospinal respiratory neurons are not activated during neuronal depression by clinically relevant opioid concentrations.
在神经元抑制期间,临床相关的阿片类药物浓度不会激活球脊髓呼吸神经元上的阿片类药物受体。
- DOI:10.1152/jn.90620.2008
- 发表时间:2008
- 期刊:
- 影响因子:2.5
- 作者:Stucke,AstridG;Zuperku,EdwardJ;Sanchez,Antonio;Tonkovic-Capin,Mislav;Tonkovic-Capin,Viseslav;Mustapic,Sanda;Stuth,EckehardA
- 通讯作者:Stuth,EckehardA
Major components of endogenous neurotransmission underlying the discharge activity of hypoglossal motoneurons in vivo.
体内舌下运动神经元放电活动的内源性神经传递的主要成分。
- DOI:10.1007/978-0-387-73693-8_49
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Zuperku,EdwardJ;Brandes,IvoF;Stucke,AstridG;Sanchez,Antonio;Hopp,FrancisA;Stuth,EckehardA
- 通讯作者:Stuth,EckehardA
Activation of 5-HT1A receptors in the preBötzinger region has little impact on the respiratory pattern.
前 Bötzinger 区域 5-HT1A 受体的激活对呼吸模式影响不大。
- DOI:10.1016/j.resp.2015.03.005
- 发表时间:2015
- 期刊:
- 影响因子:2.3
- 作者:Radocaj,Tomislav;Mustapic,Sanda;Prkic,Ivana;Stucke,AstridG;Hopp,FrancisA;Stuth,EckehardAE;Zuperku,EdwardJ
- 通讯作者:Zuperku,EdwardJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ECKEHARD A STUTH其他文献
ECKEHARD A STUTH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ECKEHARD A STUTH', 18)}}的其他基金
VOLATILE ANESTHETICS AND RESPIRATORY NEUROTRANSMISSION
挥发性麻醉剂与呼吸神经传输
- 批准号:
6386453 - 财政年份:1999
- 资助金额:
$ 24.33万 - 项目类别:
VOLATILE ANESTHETICS AND RESPIRATORY NEUROTRANSMISSION
挥发性麻醉剂与呼吸神经传输
- 批准号:
6181446 - 财政年份:1999
- 资助金额:
$ 24.33万 - 项目类别:
VOLATILE ANESTHETICS AND RESPIRATORY NEUROTRANSMISSION
挥发性麻醉剂与呼吸神经传输
- 批准号:
6636294 - 财政年份:1999
- 资助金额:
$ 24.33万 - 项目类别:
Volatile Anesthetics and Respiratory Neurotransmission
挥发性麻醉剂和呼吸神经传递
- 批准号:
7154120 - 财政年份:1999
- 资助金额:
$ 24.33万 - 项目类别:
Volatile Anesthetics and Respiratory Neurotransmission
挥发性麻醉剂和呼吸神经传递
- 批准号:
7047376 - 财政年份:1999
- 资助金额:
$ 24.33万 - 项目类别:
VOLATILE ANESTHETICS AND RESPIRATORY NEUROTRANSMISSION
挥发性麻醉剂与呼吸神经传输
- 批准号:
6519999 - 财政年份:1999
- 资助金额:
$ 24.33万 - 项目类别:
VOLATILE ANESTHETICS AND RESPIRATORY NEUROTRANSMISSION
挥发性麻醉剂与呼吸神经传输
- 批准号:
7025243 - 财政年份:1999
- 资助金额:
$ 24.33万 - 项目类别:
VOLATILE ANESTHETICS AND RESPIRATORY NEUROTRANSMISSION
挥发性麻醉剂与呼吸神经传输
- 批准号:
2828020 - 财政年份:1999
- 资助金额:
$ 24.33万 - 项目类别:
相似海外基金
Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
- 批准号:
10603466 - 财政年份:2023
- 资助金额:
$ 24.33万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 24.33万 - 项目类别:
Discovery Grants Program - Individual
Glucocorticoid and Adrenergic Receptor Signaling at the Neuroimmune Interface
神经免疫界面的糖皮质激素和肾上腺素能受体信号传导
- 批准号:
RGPIN-2019-04706 - 财政年份:2022
- 资助金额:
$ 24.33万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 24.33万 - 项目类别:
University Undergraduate Student Research Awards
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10629280 - 财政年份:2022
- 资助金额:
$ 24.33万 - 项目类别:
Angiotensin-(1-7) and beta adrenergic receptor signaling in aging
衰老过程中血管紧张素 (1-7) 和 β 肾上腺素受体信号传导
- 批准号:
10448574 - 财政年份:2022
- 资助金额:
$ 24.33万 - 项目类别:
Novel regulation of beta-adrenergic receptor function by phosphoinositide 3-kinase
磷酸肌醇 3-激酶对 β-肾上腺素能受体功能的新调节
- 批准号:
10591688 - 财政年份:2022
- 资助金额:
$ 24.33万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 24.33万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 24.33万 - 项目类别:
University Undergraduate Student Research Awards
The molecular mechanism of the crosstalk between the beta-2 adrenergic receptor and chemokine receptors in lymphocytes
淋巴细胞β2肾上腺素受体与趋化因子受体串扰的分子机制
- 批准号:
22K07118 - 财政年份:2022
- 资助金额:
$ 24.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)